Cargando…
Targeting Src in endometriosis-associated ovarian cancer
The SRC proto-oncogene is commonly overexpressed or activated during cancer development. Src family kinase inhibitors are approved for the treatment of certain leukemias, and are in clinical trials for the treatment of solid tumors. Src signaling is activated in endometriosis, a precursor of clear c...
Autores principales: | Manek, R, Pakzamir, E, Mhawech-Fauceglia, P, Pejovic, T, Sowter, H, Gayther, S A, Lawrenson, K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007828/ https://www.ncbi.nlm.nih.gov/pubmed/27526105 http://dx.doi.org/10.1038/oncsis.2016.54 |
Ejemplares similares
-
The PAX8 cistrome in epithelial ovarian cancer
por: Adler, Emily K., et al.
Publicado: (2017) -
Molecular Analysis of Mixed Endometrioid and Serous Adenocarcinoma of the Endometrium
por: Lawrenson, Kate, et al.
Publicado: (2015) -
MET/HGF Signaling Pathway in Ovarian Carcinoma: Clinical Implications and Future Direction
por: Mhawech-Fauceglia, Paulette, et al.
Publicado: (2012) -
The prognostic significance of GRB7 protein expression and localization in human breast and ovarian cancers
por: Vermehren-Schmaedick, Anke, et al.
Publicado: (2020) -
Subcellular localization of FANCD2 is associated with survival in ovarian carcinoma
por: Joshi, Sonali, et al.
Publicado: (2020)